Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Find ways to stay ahead in budgeting with routine reviews, alerts, and smart adjustments that protect your financial path.
21,896 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Hackers seized SpaceX’s X accounts to promote a meme coin, briefly lifting its price and market cap before a quick ru...
AlleyCorp unveils a new $335 million fund focused on early-stage bets in healthcare and technology. The move reinforc...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...
Travelers Insurance shares surged after a standout quarterly report, lifting the stock well above the market. This an...
Trump endorses ethics restrictions tied to the CLARITY Act, handing Democrats a pivotal decision on crypto oversight....
XRP faces a steep pullback even as investor chatter surges. Grayscale’s sentiment report brands XRP as the second-mos...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
Park Hotels 2025 earnings data in Q4 reveals how occupancy, pricing, and balance-sheet moves drive the next leg of th...
NBC’s Olympic rights are finally paying off as Milan-Cortina 2026 delivers blockbuster ratings, underscoring a vindic...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
CAVA Group's shares jumped on expansion progress, signaling investor enthusiasm for growth. This article breaks down ...